文献速递心境障碍儿童青少年精神

FMRP在快速抗抑郁效应与突触调控中的作用

Role of FMRP in rapid antidepressant effects and synapse regulation.
PubMed 文献 · Mol Psychiatry · 2021-01-12

该研究探讨RNA结合蛋白FMRP在快速抗抑郁药Ro-25-6981行为效应和突触调控中的作用,发现其行为效应需要FMRP表达,且治疗以mTORC1依赖方式促进FMRP与不同mRNA结合,这些mRNA调控跨突触信号。在缺乏FMRP的脆性X综合征动物模型中,GABABR活性对Ro-25-6981效应有害,联合阻断GABABR与NMDAR可挽救,提示快速抗抑郁药单用可能对共病FXS与MDD者无效。

要点

  • 快速抗抑郁药Ro-25-6981的行为效应需要FMRP表达。
  • Ro-25-6981以mTORC1依赖方式促进FMRP与调控跨突触信号的mRNA差异结合。
  • 在缺乏FMRP的FXS模型中,联合阻断GABABR与NMDAR可挽救Ro-25-6981效应。

核心结论

  • 快速抗抑郁药Ro-25-6981的行为效应需要FMRP表达,且治疗以mTORC1依赖方式改变FMRP的mRNA结合。
  • 在缺乏FMRP表达的脆性X综合征动物模型中,GABABR活性对Ro-25-6981效应有害,联合阻断GABABR与NMDAR可挽救。
  • 快速抗抑郁药单用可能对共病脆性X综合征与重性抑郁障碍者不是有效治疗。

研究设计与样本

  • 研究采用动物实验,使用快速抗抑郁药Ro-25-6981处理,并在野生型动物及缺乏FMRP表达的脆性X综合征动物模型中观察行为与突触效应。

主要发现

  • Ro-25-6981的行为效应需要FMRP表达。
  • Ro-25-6981处理以mTORC1依赖方式促进FMRP与不同mRNA差异结合,这些mRNA调控跨突触信号。
  • 在野生型动物中,Ro-25-6981行为效应所依赖的突触形成需要GABABR介导的mTORC1活性。
  • 在缺乏FMRP表达的脆性X综合征动物模型中,GABABR活性对Ro-25-6981效应有害。
  • 联合阻断GABABR与NMDAR可挽救脆性X综合征模型中Ro-25-6981的效应。

临床怎么用

  • 快速抗抑郁药单用可能对共病脆性X综合征与重性抑郁障碍者不是有效治疗,需考虑联合阻断GABABR与NMDAR的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rapid antidepressants are novel treatments for major depressive disorder (MDD) and work by blocking N-methyl-D-aspartate receptors (NMDARs), which, in turn, activate the protein synthesis pathway regulated by mechanistic/mammalian target of rapamycin complex 1 (mTORC1). Our recent work demonstrates that the RNA-binding protein Fragile X Mental Retardation Protein (FMRP) is downregulated in dendrites upon treatment with a rapid antidepressant. Here, we show that the behavioral effects of the rapid antidepressant Ro-25-6981 require FMRP expression, and treatment promotes differential mRNA binding to FMRP in an mTORC1-dependent manner. Further, these mRNAs are identified to regulate transsynaptic signaling. Using a novel technique, we show that synapse formation underlying the behavioral effects of Ro-25-6981 requires GABABR-mediated mTORC1 activity in WT animals. Finally, we demonstrate that in an animal model that lacks FMRP expression and has clinical relevance for Fragile X Syndrome (FXS), GABABR activity is detrimental to the effects of Ro-25-6981. These effects are rescued with the combined therapy of blocking GABABRs and NMDARs, indicating that rapid antidepressants alone may not be an effective treatment for people with comorbid FXS and MDD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Heaney CF, Namjoshi SV, Uneri A, et al. Role of FMRP in rapid antidepressant effects and synapse regulation. Mol Psychiatry. 2021. PMID: 33432187. doi:10.1038/s41380-020-00977-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。